Trial Profile
An observational pharmacokinetic trial of bevacizumab to evaluate the interaction between bevacizumab and Vascular Endothelial Growth Factor (VEGF) in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Pharmacokinetics
- 03 Nov 2015 New trial record